Tempest Therapeutics (TPST) Asset Utilization Ratio (2015 - 2018)
Tempest Therapeutics (TPST) posted Asset Utilization Ratio of 0.01 for Q3 2018, up 12.78% sequentially from 0.0 in Q2 2018, and up 52.36% YoY from 0.0 in Q3 2017.
Tempest Therapeutics (TPST) Asset Utilization Ratio (2015 - 2018) Analysis & Trends
Tempest Therapeutics has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.01 in Q3 2018.
- Quarterly Asset Utilization Ratio rose 52.36% year-over-year to 0.01 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was 0.01 (up 52.36% YoY) and the FY2017 annual result came in at 0.0, down 36.41% from the prior year.
- Asset Utilization Ratio rose to 0.01 in Q3 2018 per TPST's latest filing, from 0.0 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.01 in Q3 2018 and troughed at 0.0 in Q1 2015.
- A 4-year average of 0.0 and a median of 0.0 in 2017 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2016 and 2017: Asset Utilization Ratio soared 2418.36% in 2016, then decreased 19.5% in 2017.
- Over 4 years, Asset Utilization Ratio stood at 0.0 in 2015, then surged by 159.3% to 0.0 in 2016, then declined by 17.75% to 0.0 in 2017, then surged by 38.43% to 0.01 in 2018.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.0, and 0.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.00 |
| Dec 31, 2017 | 0.00 |
| Sep 30, 2017 | 0.00 |
| Jun 30, 2017 | 0.00 |
| Mar 31, 2017 | 0.00 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | 0.00 |
| Jun 30, 2016 | 0.00 |
| Mar 31, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |
| Sep 30, 2015 | 0.00 |
| Jun 30, 2015 | 0.00 |
| Mar 31, 2015 | 0.00 |